4-aminoimidazole has been researched along with Obesity in 1 studies
4-aminoimidazole: structure in first source
4-aminoimidazole : An aminoimidazole that is 1H-imidazole substituted by an amino group at position 4.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bikman, BT | 1 |
| Zheng, D | 1 |
| Reed, MA | 1 |
| Hickner, RC | 1 |
| Houmard, JA | 1 |
| Dohm, GL | 1 |
1 other study available for 4-aminoimidazole and Obesity
| Article | Year |
|---|---|
Lipid-induced insulin resistance is prevented in lean and obese myotubes by AICAR treatment.
Topics: Aminoimidazole Carboxamide; Body Mass Index; Fatty Acids; Female; Humans; Imidazoles; Insulin; Insul | 2010 |